Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 22;3(4):e1162897.
doi: 10.1080/23723556.2016.1162897. eCollection 2016 Jul.

Functional versus non-functional intratumor heterogeneity in cancer

Affiliations

Functional versus non-functional intratumor heterogeneity in cancer

Marc J Williams et al. Mol Cell Oncol. .

Abstract

Next-generation sequencing data from human cancers are often difficult to interpret within the context of tumor evolution. We developed a mathematical model describing the accumulation of mutations under neutral evolutionary dynamics and showed that 323/904 cancers (∼30%) from multiple types were consistent with the neutral model of tumor evolution.

Keywords: Cancer genome; intratumor heterogeneity; mathematical model; mutation rate; neutral expansion; site-frequency spectrum.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mutations and their frequency determine the history of individual tumors. (A) Mutations label distinct lineages and as a tumor grows the size of these lineages becomes progressively smaller. Here, with one mutation per division and all cells growing at the same rate, the 2 mutations occurring during the first division are each present in 50% of the population, whereas mutations occurring during the final division are present in 12.5%. (B) When sequencing tumor biopsies we measure the frequency f of mutations in the population. Neutral tumor evolution imprints a characteristic 1/f signature in the distribution of subclonal mutant allele frequencies.

References

    1. Williams MJ, Werner B, Barnes CP, Graham TA, Sottoriva A. Identification of neutral tumor evolution across cancer types. Nat Genet 2016; 48:3; 238–244; http://dx.doi.org/10.1038/ng.3489 - DOI - PMC - PubMed
    1. Durrett R. Population genetics of neutral mutations in exponentially growing cancer cell populations. Ann Appl Probability 2013; 23:230-50; PMID:23471293; http://dx.doi.org/10.1214/11-AAP824 - DOI - PMC - PubMed
    1. Griffiths RC, Tavaré S. The age of a mutation in a general coalescent tree. Communications in Statistics. Stochastic Models 1998; 14:273-95; http://dx.doi.org/10.1080/15326349808807471 - DOI
    1. Jones S. et al.. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 2008; 105:4283-8; PMID:18337506; http://dx.doi.org/10.1073/pnas.0712345105 - DOI - PMC - PubMed
    1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67; PMID:2188735; http://dx.doi.org/10.1016/0092-8674(90)90186-I - DOI - PubMed

LinkOut - more resources